Stock Notes

RPG Life Sciences

Every Finvezto stock note on RPG Life Sciences, dated and newest first. Coverage spans pharmaceuticals.

1 note and counting
03 Sep 2026
RPG Life Sciences arm RPG Active Pharma agreed to buy the API and intermediates business of Raghava Life Sciences for up to 135 crore rupees.
The slump sale adds 22 commercialised APIs, seven development assets and a WHO-GMP and EU-GMP plant near Hyderabad, the second API acquisition after Actis Generics.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.